Halozyme Therapeutics (HALO) – Hot FDA News
-
Halozyme Therapeutics (HALO) Reports Positive Results from Phase III IMscin001 Study
-
Halozyme Therapeutics (HALO) Reports HALO-301 Phase 3 Study Fails To Meet Primary Endpoint
-
-
-
-
-
-
-
-
-
-
Back to HALO Stock Lookup